Cargando…

In Search of the Appropriate Anticoagulant-Associated Bleeding Risk Assessment Model for Cancer-Associated Thrombosis Patients

SIMPLE SUMMARY: Patients with venous thromboembolism events in the context of cancer should receive anticoagulants as long as the cancer is active. Therefore, a tailor-made anticoagulation strategy should rely on an individualized assessment of the risks of recurrent venous thromboembolism and antic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Poénou, Géraldine, Tolédano, Emmanuel, Helfer, Hélène, Plaisance, Ludovic, Happe, Florent, Versini, Edouard, Diab, Nevine, Djennaoui, Sadji, Mahé, Isabelle
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Systematic Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9029420/ https://www.ncbi.nlm.nih.gov/pubmed/35454844 http://dx.doi.org/10.3390/cancers14081937

Ejemplares similares

Assessment of bleeding risk in cancer patients treated with anticoagulants for venous thromboembolic events
por: Poénou, Géraldine, et al.
Publicado: (2023)

Diagnostic Approach for Venous Thromboembolism in Cancer Patients
por: Helfer, Hélène, et al.
Publicado: (2023)

Reasons Influencing Long-Term Anticoagulant Treatment Beyond 6 Months for Cancer-Associated Thrombosis in USCAT, A 432-Patient Retrospective Non-Interventional Study
por: Plaisance, Ludovic, et al.
Publicado: (2021)

Cancer-Associated Thrombosis on Bevacizumab: Risk of Recurrence and Bleeding When Bevacizumab Is Stopped or Continued
por: Mayenga, Marie, et al.
Publicado: (2023)

Outside any therapeutic trial prescription of hydroxychloroquine for hospitalized patients with covid-19 during the first wave of the pandemic: A national inquiry of prescription patterns among French hospitalists
por: Bosquet, Antoine, et al.
Publicado: (2022)

Granulosa tumor: two spontaneous pregnancies after combined medico-surgical treatment: case report and review of the literature
por: Kaakoua, Mohamed, et al.
Publicado: (2023)

Long-Term Treatment of Cancer-Associated Thrombosis (CAT) Beyond 6 Months in the Medical Practice: USCAT, a 432-Patient Retrospective Non-Interventional Study
por: Mahé, Isabelle, et al.
Publicado: (2020)

Management of Cancer-Associated Thrombosis in France: A National Survey among Vascular Disease and Supportive Care Specialists
por: Mahé, Isabelle, et al.
Publicado: (2022)

Pulmonary Embolism in the Cancer Associated Thrombosis Landscape
por: Poenou, Géraldine, et al.
Publicado: (2022)

Extended anticoagulation treatment for cancer‐associated thrombosis—Rates of recurrence and bleeding beyond 6 months: A systematic review
por: Moik, Florian, et al.
Publicado: (2021)

Rates of rebleeding, thrombosis and mortality associated with resumption of anticoagulant therapy after anticoagulant-related bleeding
por: Little, Derek H.W., et al.
Publicado: (2021)

Anticoagulants: A Short History, Their Mechanism of Action, Pharmacology, and Indications
por: Heestermans, Marco, et al.
Publicado: (2022)

Microbleed prevalence and burden in anticoagulant‐associated intracerebral bleed
por: Lioutas, Vasileios‐Arsenios, et al.
Publicado: (2019)

Treatment response and bleeding events associated with anticoagulant therapy of portal vein thrombosis in cirrhotic patients: Systematic review and meta-analysis
por: Mohan, Babu P., et al.
Publicado: (2020)

Cancer‐associated thrombosis: Role of direct oral anticoagulants
por: Ikeda, Masataka, et al.
Publicado: (2018)

Comparative Effectiveness of Anticoagulants in Patients With Cancer-Associated Thrombosis
por: Riaz, Irbaz Bin, et al.
Publicado: (2023)

A Short Course of Tranexamic Acid to Continue Anticoagulation and Control Bleed in Cerebral Venous Thrombosis with Abnormal Uterine Bleeding and Anemia
por: Jha, Shreyashi, et al.
Publicado: (2022)

Bleeding, thrombosis, and anticoagulation in myeloproliferative neoplasms (MPN): analysis from the German SAL-MPN-registry
por: Kaifie, A., et al.
Publicado: (2016)

Anticoagulant Therapy in Thrombosis
por: Jorpes, J. Erik
Publicado: (1946)

The Role of Excessive Anticoagulation and Missing Hyperinflammation in ECMO-Associated Bleeding
por: Rajsic, Sasa, et al.
Publicado: (2022)

The Role of Direct Oral Anticoagulants in Treatment of Cancer-Associated Thrombosis
por: Al-Samkari, Hanny, et al.
Publicado: (2018)

Serious Complication of Anticoagulation in Vessel Thrombosis-associated Behçet Disease
por: Ouchi, Kotaro, et al.
Publicado: (2020)

Treatment of Cancer-Associated Thrombosis: Beyond HOKUSAI
por: Mahé, Isabelle, et al.
Publicado: (2019)

Thyroid Autoimmunity and Antiphospholipid Syndrome: Not Such a Trivial Association
por: Versini, Mathilde
Publicado: (2017)

Factor XI Inhibition for the Prevention of Venous Thromboembolism: An Update on Current Evidence and Future perspectives
por: Poenou, Geraldine, et al.
Publicado: (2022)

Thrombosis and Bleeding Disorders
por: Nemerson, Yale
Publicado: (1971)

Thrombosis Prevention without Anticoagulation
por: Schmaier, Alvin H.
Publicado: (2014)

Thrombosis and anticoagulation in COVID-19
por: Ramos, Roberta Pulcheri, et al.
Publicado: (2020)

Erratum: Treatment of Cancer-Associated Thrombosis: Beyond HOKUSAI
por: Mahé, Isabelle, et al.
Publicado: (2019)

Non-Vitamin K Oral Anticoagulants Associated Bleeding and Its Antidotes
por: Steiner, Thorsten, et al.
Publicado: (2018)

Reversal agents for oral anticoagulant-associated major or life-threatening bleeding
por: Moia, Marco, et al.
Publicado: (2019)

Bleeding Complications Associated With Intrauterine Contraception in Women Receiving Anticoagulation Therapy
por: O’Laughlin, Danielle J., et al.
Publicado: (2022)

Association between Genetic Polymorphisms and Bleeding in Patients on Direct Oral Anticoagulants
por: Yoon, Ha-Young, et al.
Publicado: (2022)

Anticoagulation stewardship: Descriptive analysis of a novel approach to appropriate anticoagulant prescription
por: Koolian, Maral, et al.
Publicado: (2022)

Anticoagulation Therapy for Pregnancy-Associated Thrombosis: A Retrospective Observational Study
por: Umetsu, Michihisa, et al.
Publicado: (2022)

Direct Oral Anticoagulants for the Prevention and Acute Treatment of Cancer-Associated Thrombosis
por: Attard, Laura M, et al.
Publicado: (2022)

Gastrointestinal Bleeding and Anticoagulant or Antiplatelet Drugs: Systematic Search for Clinical Practice Guidelines
por: Gutermann, Irit Kaye, et al.
Publicado: (2015)

Correction to: Reversal agents for oral anticoagulant-associated major or life-threatening bleeding
por: Moia, Marco, et al.
Publicado: (2019)

Understanding Bleeding Risk after Anticoagulation
Publicado: (2005)

Restart of Anticoagulant Therapy and Risk of Thrombosis, Rebleeding, and Death after Factor Xa Inhibitor Reversal in Major Bleeding Patients
por: Milling, Truman J., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_606or4djt4lhi92k3uu52kqepp